Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06758011 · ClinicalTrials.gov registry record · NA
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,400
- Enrollment target
NCT06758011: Completed NA study, sponsored by Roswell Park Cancer Institute.
NCT06758011 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 2,400 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06758011, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,400 participants
- Enrollment target
Study Summary
This study aims to determine the feasibility of using the ivWatch (registered trademark) device to determine if there is an infiltration at the site of a peripheral intravenous (PIV) catheter. An infiltration is when the IV fluid leaks out of a vein and into the surrounding tissue. If medication starts leaking outside the vein, it can cause damage to the surrounding tissue. Using the ivWatch device may identify leaking fluid before the nurse is able to visually observe the signs or symptoms of the leaking fluid.
Primary Outcome
Evaluated by the ratio of number ivWatch used for vesicant therapy over the total number of vesicant therapies for study participants
Interventions
- DEVICE ivWatch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Start Date | 2023-05-17 |
| Est. Completion | 2026-01-26 |
| Phase | NA |
What the finished NCT06758011 record still lists
NCT06758011 is an interventional study that assigns participants to a tested intervention. Its 2,400 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% higher).
The record links to 0 conditions, and to 1 intervention - of which ivWatch is the first listed.
NCT06758011 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06758011 about?
NCT06758011 is a clinical study titled "ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting". This study aims to determine the feasibility of using the ivWatch (registered trademark) device to determine if there is an infiltration at the site of a peripheral intravenous (PIV) catheter. An infiltration is when the IV fluid leaks out of a vein and into the surrounding tissue. If medication sta...
What is the current status of trial NCT06758011?
This trial is currently completed. It is a NA study. The enrollment target is 2,400 participants. The study started on 2023-05-17. Estimated completion is 2026-01-26.
What interventions are being tested in trial NCT06758011?
The interventions under investigation include: ivWatch (DEVICE).
Who is sponsoring clinical trial NCT06758011?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06758011's enrollment target sits among peer trials
2,400 46th of 2000 higher than 1,955 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
- NCT05738330 · 2,400 participants · NA
Symptom Monitoring in Hemodialysis
- NCT05833360 · 2,400 participants
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI